Covered recipient · General Payments record
ALEXANDRA BOURGEOIS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$1,243.74
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $728.60 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $164.40 | 7 |
| ABBVIE INC. | $150.97 | 9 |
| UCB, Inc. | $137.82 | 4 |
| Janssen Biotech, Inc. | $78.88 | 4 |
| E.R. Squibb & Sons, L.L.C. | $58.14 | 4 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $46.17 | 2 |
| Lilly USA, LLC | $32.58 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.46 | 1 |
| Journey Medical Corporation | $20.98 | 1 |
| GENZYME CORPORATION | $15.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.53 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353922 | CMS |
| ABBVIE INC. | $19.90 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353924 | CMS |
| ABBVIE INC. | $18.71 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353926 | CMS |
| ABBVIE INC. | $19.35 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353928 | CMS |
| ABBVIE INC. | $2.47 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353930 | CMS |
| ABBVIE INC. | $13.54 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353932 | CMS |
| ABBVIE INC. | $21.02 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353934 | CMS |
| ABBVIE INC. | $19.62 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353936 | CMS |
| ABBVIE INC. | $15.83 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103353938 | CMS |
| Amgen Inc. | $29.72 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117207790 | CMS |
| Amgen Inc. | $1.99 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117207792 | CMS |
| Amgen Inc. | $31.90 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117207794 | CMS |
| Amgen Inc. | $33.73 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117207796 | CMS |
| Amgen Inc. | $1.94 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117207798 | CMS |
| Amgen Inc. | $31.68 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117207800 | CMS |
| Amgen Inc. | $33.44 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117207802 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.12 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101854880 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.12 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101854891 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.37 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101854956 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.53 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101854989 | CMS |
| GENZYME CORPORATION | $15.20 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139923643 | CMS |
| Janssen Biotech, Inc. | $24.48 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078815809 | CMS |
| Janssen Biotech, Inc. | $20.84 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078816400 | CMS |
| Janssen Biotech, Inc. | $16.99 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078816531 | CMS |
| Janssen Biotech, Inc. | $16.57 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078817205 | CMS |
| Journey Medical Corporation | $20.98 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100054873 | CMS |
| Lilly USA, LLC | $18.08 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135996484 | CMS |
| Lilly USA, LLC | $14.50 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136017557 | CMS |
| Novartis Pharmaceuticals Corporation | $23.46 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086773365 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $32.08 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152122134 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.09 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152122136 | CMS |
| UCB, Inc. | $29.87 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143019983 | CMS |
| UCB, Inc. | $31.52 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143019985 | CMS |
| UCB, Inc. | $38.56 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143019987 | CMS |
| UCB, Inc. | $37.87 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143019989 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.